CAVALLA DAVID has a total of 11 patent applications. Its first patent ever was published in 2000. It filed its patents most often in United Kingdom, United States and WIPO (World Intellectual Property Organization). Its main competitors in its focus markets pharmaceuticals and organic fine chemistry are LINK MEDICINE CORP, TIANJIN TIANSHILI PHARMACEUTIC and LILLY ICOS LLC.
# | Country | Total Patents | |
---|---|---|---|
#1 | United Kingdom | 5 | |
#2 | United States | 4 | |
#3 | WIPO (World Intellectual Property Organization) | 2 |
# | Industry | |
---|---|---|
#1 | Pharmaceuticals | |
#2 | Organic fine chemistry |
# | Technology | |
---|---|---|
#1 | Therapeutic chemical compounds | |
#2 | Medical preparations | |
#3 | Heterocyclic compounds |
# | Name | Total Patents |
---|---|---|
#1 | Cavalla David | 6 |
#2 | Gristwood Robert W | 2 |
#3 | Chasin Mark | 1 |
#4 | Wintergest Peter | 1 |
#5 | Hofer Peter | 1 |
#6 | Gehrig Andre | 1 |
Publication | Filing date | Title |
---|---|---|
GB0814881D0 | New threapeutic use | |
GB0814882D0 | New threapeutic use | |
GB0723757D0 | Treatment of cachexia | |
GB0624282D0 | Treatment of cachexia | |
GB0624202D0 | Treatment of cachexia | |
US2006167005A1 | New therapeutic uses of (4-(2-fluorophenyl)-6-methyl-2-(1-piperazinyl) thieno [2,3-d] pyrimidine |